Edmonton biotechnology company hopeful its COVID-19 vaccine will continue along approval process

Dylan Short - 16 February 2021

John Lewis, U of A researcher and CEO of Entos Pharmaceuticals, said his company is currently working on two DNA vaccines and is waiting to start the next phase of its COVID-19 vaccine approval after the federal government announced tens of millions of dollars to support vaccine production. Story also notes that the Li Ka Shing Applied Virology Institute at the U of A has developed a vaccine and quotes U of A virologist Michael Houghton.

Read More....